Erythropoietin and platelet production

Haematologica

Volumn 84, Issue 6, 1999, Pages 541-547

  Beguin, Yves ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Erythropoiesis; Erythropoietin; Hypoxia; Iron deficiency; Megakaryopoiesis; Platelets

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; THROMBOPOIETIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DOSE TIME EFFECT RELATION; DRUG SAFETY; HORMONAL REGULATION; HUMAN; MEGAKARYOPOIESIS; NONHUMAN; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

BLOOD PLATELETS; ERYTHROPOIETIN; HEMATOPOIESIS; HUMANS; REVIEW LITERATURE;

EID: 0033063240     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (101)

1. Lacombe C, Mayeux P. Biology of erythropoietin. Haematologica 1998; 83:724-32.
2. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987; 316:73-8.
3. Fabris F, Cordiano I, Randi ML, et al. Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis. Pediatr Nephrol 1991; 5:225-8.
4. Akizawa T, Kinugasa E, Kitaoka T, Koshikawa S. Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients. Nephron 1991; 58:400-6.
5. Taylor JE, Henderson IS, Stewart WK, Belch JJ. Erythropoietin and spontaneous platelet aggregation in haemodialysis patients. Lancet 1991; 338:1361-2.
6. Zwaginga JJ, IJsseldijk MJ, de Groot PG, et al. Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma. Thromb Haemost 1991; 66: 638-47.
7. Viganò G, Benigni A, Mendogni D, Mingardi G, Mecca G, Remuzzi G. Recombinant human erythropoietin to correct uremic bleeding. Am J Kidney Dis 1991; 18:44-9.
8. Eschbach JW, Abdulhadi MH, Browne JK, et al. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 1989; 111:992-1000.
9. Beguin Y, Loo M, R'Zik S, et al. Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters. Eur J Haematol 1994; 53:265-70.
10. McDonald TP, Cottrell MB, Clift RE, Cullen WC, Lin FK. High doses of recombinant erythropoietin stimulate platelet production in mice. Exp Hematol 1987; 15:719-21.
11. Berridge MV, Fraser JK, Carter JM, Lin FK. Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat. Blood 1988; 72: 970-7.
12. Shikama Y, Ishibashi T, Kimura H, Kawaguchi M, Uchida T, Maruyama Y. Transient effect of erythropoietin on thrombocytopoiesis in vivo in mice. Exp Hematol 1992; 20:216-22.
13. Yonemura Y, Kawakita M, Fujimoto K, et al. Effects of short-term administration of recombinant human erythropoietin on rat megakaryopoiesis. Int J Cell Cloning 1992; 10:18-27.
14. McDonald TP, Clift RE, Cottrell MB. Large, chronic doses of erythropoietin cause thrombocytopenia in mice. Blood 1992; 80:352-8.
15. McDonald TP, Sullivan PS. Megakaryocytic and erythrocytic cell lines share a common precursor cell. Exp Hematol 1993; 21:1316-20.
16. Karpatkin S, Garg SK, Freedman ML Role of iron as a regulator of thrombopoiesis. Am J Med 1974; 57:521-5.
17. Jackson CW, Simone JV, Edwards CC. The relationship of anemia and thrombocytosis. J Lab Clin Med 1974; 84:357-68.
18. Jackson CW, Edwards CC. Biphasic thrombopoietic response to severe hypobaric hypoxia. Br J Haematol 1977; 35:233-44.
19. McDonald TP, Cottrell MB, Steward SA, Clift RE, Swearingen CJ, Jackson CW. Comparison of platelet production in two strains of mice with different modal megakaryocyte DNA ploidies after exposure to hypoxia. Exp Hematol 1992; 20:51-6.
20. McDonald TP, Cottrell MB, Clift R. Effects of short-term hypoxia on platelet counts in mice. Blood 1978; 51:165-75.
21. McDonald TP. Platelet production in hypoxic and RBC-transfused mice. Scand J Haematol 1978; 20:213-20.
22. Langdon JR, McDonald TP. Effects of chronic hypoxia on platelet production in mice. Exp Hematol 1977; 5:191-8.
23. Birks JW, Klassen LW, Gurney CW. Hypoxia-induced thrombocytopenia in mice. J Lab Clin Med 1975; 86: 230-8.
24. Cooper GW, Cooper B. Relationships between blood platelet and erythrocyte formation. Life Sci 1977; 20: 1571-9.
25. Petursson SR, Chervenick PA. Effects of hypoxia on megakaryocytopoiesis and granulopoiesis. Eur J Haematol 1987; 39:267-73.
26. McDonald TP, Cullen WC, Cottrell M, Clift R. Effects of hypoxia on the small acetylcholinesterase-positive megakaryocyte precursor in bone marrow of mice. Proc Soc Exp Biol Med 1986; 183:114-7.
27. Rolovic Z, Basara N, Biljanovic Paunovic L, Stojanovic N, Suvajdzic N, Pavlovic Kentera V. Megakaryocytopoiesis in experimentally induced chronic normobaric hypoxia. Exp Hematol 1990; 18:190-4.
28. McDonald TP, Cottrell MB, Clift RE, Jackson CW. Effects of hypoxia on megakaryocyte size and number of C3H and BALB/c mice. Proc Soc Exp Biol Med 1992; 199:287-90.
29. McDonald TP, Cottrell M, Clift R. Effects of hypoxia on thrombocytopoiesis and thrombopoietin production of mice. Proc Soc Exp Biol Med 1979; 160:335-9.
30. Cullen WC, McDonald TP. Effects of isobaric hypoxia on murine medullary and splenic megakaryocytopoiesis. Exp Hematol 1989; 17:246-51.
31. Layendecker SJ, McDonald TP. The relative roles of the spleen and bone marrow in platelet production in mice. Exp Hematol 1982; 10:332-42.
32. Cottrell MB, Jackson CW, McDonald TP. Hypoxia increases erythropoiesis and decreases thrombocytopoiesis in mice: a comparison of two mouse strains. Proc Soc Exp Biol Med 1991; 197:261-7.
33. Nohr ML. Inefficacy of erythropoietic response of BALB/c mice to hypoxia. Am J Physiol 1967; 213:1285-9.
34. Shaikh BS, Erslev AJ. Thrombocytopenia in polycythemic mice. J Lab Clin Med 1978; 92:765-71.
35. McDonald TP. A comparison of platelet production in mice made thrombocytopenic by hypoxia and by platelet specific antisera. Br J Haematol 1978; 40:299-309.
36. Cipolleschi MG, D'Ippolito G, Bernabei PA, et al. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro. Exp Hematol 1997; 25:1187-94.
37. La Iuppa JA, Papoutsakis ET, Miller WM. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages. Exp Hematol 1998; 26:835-43.
38. Pirisi M, Fabris C, Soardo G, Cecchin E, Toniutto P, Bartoli E. Thrombocytopenia of chronic liver disease corrected by erythropoietin treatment. J Hepatol 1994; 21:376-80.
39. Sowade O, Ziemer S, Sowade B, et al. The effect of preoperative recombinant human erythropoietin therapy on platelets and hemostasis in patients undergoing cardiac surgery. J Lab Clin Med 1997; 129:376-83.
40. George JW, Bracco CA, Shannon KM, et al. Age-related differences in erythropoietic response to recombinant human erythropoietin: comparison in adult and infant rhesus monkeys. Pediatr Res 1990; 28:567-71.
41. Wolf RF, Peng J, Friese P, Gilmore LS, Burstein SA, Dale GL. Erythropoietin administration increases production and reactivity of platelets in dogs. Thromb Haemost 1997; 78:1505-9.
42. Tsukada J, Misago M, Kikuchi M, et al. The effect of high doses of recombinant human erythropoietin on megakaryocytopoiesis and platelet production in splenectomized mice. Br J Haematol 1990; 76:260-8.
43. Grossi A, Vannucchi AM, Rafanelli D, Ferrini PR. Recombinant human erythropoietin has little influence on megakaryocytopoiesis in mice. Br J Haematol 1989; 71:463-8.
44. Semenza GL, Traystman MD, Gearhart JD, Antonarakis SE. Polycythemia in transgenic mice expressing the human erythropoietin gene. Proc Natl Acad Sci USA 1989; 86:2301-5.
45. Sullivan PS, McDonald TP. Thyroxine suppresses thrombocytopoiesis and stimulates erythropoiesis in mice. Proc Soc Exp Biol Med 1992; 201:271-7.
46. Sullivan PS, Jackson CW, McDonald TP. Castration decreases thrombocytopoiesis and testosterone restores platelet production in castrated BALB/c mice: evidence that testosterone acts on a bipotential hematopoietic precursor cell. J Lab Clin Med 1995; 125:326-33.
47. Evatt BL, Spivak JL, Levin J. Relationships between thrombopoiesis and erythropoiesis: with studies of the effects of preparations of thrombopoietin and erythropoietin. Blood 1976; 48:547-58.
48. Ulich TR, del Castillo J, Senaldi G, et al. Systemic hematologic effects of PEC-rHuMCDF-induced megakaryocyte hyperplasia in mice. Blood 1996; 87:5006-15.
49. Yan XQ, Lacey D, Fletcher F, et al. Chronic exposure to retroviral vector encoded mgdf(mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 1995; 86:4025-33.
50. Neelis KJ, Qingliang L, Thomas GR, Cohen BL, Eaton DL, Wagemaker G. Prevention ofthrombocytopenia by thrombopoietin in myelosuppressed rhesus monkeys accompanied by prominent erythropoietic stimulation and iron depletion. Blood 1997; 90:58-63.
51. Molineux G, Hartley CA, McElroy P, McCrea C, McNiece IK. Megakaryocyte growth and development factor stimulates enhanced platelet recovery in mice after bone marrow transplantation. Blood 1996; 88:1509-14.
52. Ekert H, Gilchrist GS, Stanton R, Hammond D. Hemostasis in cyanotic congenital heart disease. J Pediatr 1970; 76:221-30.
53. Maurer HM, McCue CM, Robertson LW, Haggins JC Correction of platelet dysfunction and bleeding in cyanotic congenital heart disease by simple red cell volume reduction. Am J Cardiol 1975; 35:831-5.
54. Hirsh J, Dacie JV. Persistent post-splenectomy thrombocytosis and thrombo-embolism: a consequence of continuing anaemia. Br J Haematol 1966; 12:44-53.
55. Hughes RT, Cotes PM, Pippard MJ, et al. Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessment. Br J Haematol 1990; 75:268-73.
56. Fraser JK, Tan AS, Lin FK, Berridge MV. Expression of specific high-affinity binding sites for erythropoietin on rat and mouse megakaryocytes. Exp Hematol 1989; 17:10-6.
57. Sasaki H, Hirabayashi Y, Ishibashi T, et al. Effects of erythropoietin, IL-3, IL-6 and LIF on a murine megakaryoblastic cell line: growth enhancement and expression of receptor mRNAs. Leuk Res 1995; 19:95-102.
58. Yoshida T, Ishida Y, Sasaki H, Inoue T, Kaku K, Kaneko T. Expression of high affinity binding sites for erythropoietin on L8057 cells, a mouse megakaryoblastic cell line, associated with cell differentiation. Am J Hematol 1992; 39:32-8.
59. Hermine O, Mayeux P, Titeux M, et al. Granulocyte-macrophage colony-stimulating factor and erythropoietin act competitively to induce two different programs of differentiation in the human pluripotent cell line UT-7. Blood 1992; 80:3060-9.
60. Dubart A, Feger F, Lacout C, Goncalves F, Vainchenker W, Dumenil D. Murine pluripotent hematopoietic progenitors constitutively expressing a normal erythropoietin receptor proliferate in response to erythropoietin without preferential erythroid cell differentiation. Mol Cell Biol 1994; 14:4834-42.
61. Longmore GD, Pharr P, Neumann D, Lodish HF. Both megakaryopoiesis and erythropoiesis are induced in mice infected with a retrovirus expressing an oncogenic erythropoietin receptor. Blood 1993; 82:2386-95.
62. Ishibashi T, Koziol JA, Burstein SA. Human recombinant erythropoietin promotes differentiation of murine megakaryocytes in vitro. J Clin Invest 1987; 79:286-9.
63. Dessypris EN, Gleaton JH, Armstrong OL. Effect of human recombinant erythropoietin on human marrow megakaryocyte colony formation in vitro. Br J Haematol 1987; 65:265-9.
64. Burstein SA, Ishibashi T. Erythropoietin and megakaryocytopoiesis. Blood Cells 1989; 15:193-201.
65. Sakaguchi M, Kawakita M, Matsushita J, Shibuya K, Koishihara Y, Takatsuki K. Human erythropoietin stimulates murine megakaryopoiesis in serum-free culture. Exp Hematol 1987; 15:1028-34.
66. Clark DA, Dessypris EN. Effects of recombinant erythropoietin on murine megakaryocytic colony formation in vitro. J Lab Clin Med 1986; 108:423-9.
67. Withy RM, Rafield LF, Beck AK, Hoppe H, Williams N, McPherson JM. Growth factors produced by human embryonic kidney cells that influence megakaryopoiesis include erythropoietin, interleukin 6, and transforming growth factor-beta. J Cell Physiol 1992; 153:362-72.
68. Tsukada J, Misago M, Kikuchi M, et al. Interactions between recombinant human erythropoietin and serum factor(s) on murine megakaryocyte colony formation. Blood 1992; 80:37-45.
69. An E, Ogata K, Kuriya S, Nomura T. Interleukin-6 and erythropoietin act as direct potentiators and inducers of in vitro cytoplasmic process formation on purified mouse megakaryocytes. Exp Hematol 1994; 22:149-56.
70. Cardier JE, Erickson-Miller CL, Murphy MJJ. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions. Stem Cells 1997; 15:286-90.
71. Ishida Y, Yano S, Yoshida T, et al. Biological effects of recombinant erythropoietin, granulocyte- macrophage colony-stimulating factor, interleukin 3, and interleukin 6 on purified rat megakaryocytes. Exp Hematol 1991; 19:608-12.
72. Dessypris E, Graber SE, Krantz SB, Stone WJ. Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo. Blood 1988; 72:2060-2.
73. Beguin Y, Loo M, R'Zik S, et al. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood 1993; 82:2010-6.
74. Schloesser LL, Kipp MA, Wenzel FJ. Thrombocytosis in iron-deficiency anemia. J Lab Clin Med 1965; 66:107-14.
75. Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest 1969; 48:963-74.
76. Holter PH, Refsum HE. Postnatal anemia and thrombocytosis in suckling rabbits: influence of delayed weaning and iron supplies. Pediatr Hematol Oncol 1988; 5:157-68.
77. Dincol K, Aksoy M. On the platelet levels in chronic iron deficiency anemia. Acta Haematol 1969; 41:135-43.
78. Kasper CK, Whissell YE, Wallerstein RO. Clinical aspects of iron deficiency. JAMA 1965; 191:359-63.
79. Choi SI, Simone JV, Jackson CW. Megakaryocytopoiesis in experimental iron deficiency anemia. Blood 1974; 43:111-20.
80. Choi SI, Simone JV. Platelet production in experimental iron deficiency anemia. Blood 1973; 42:219-28.
81. Dinçol K, Aksoy M. On the platelet levels in chronic iron deficiency anemia. Acta Haematol 1969; 41:135-43.
82. Berger M, Brass LF. Severe thrombocytopenia in iron deficiency anemia. Am J Hematol 1987; 24:425-8.
83. Lopas H, Rabiner SF. Thrombocytopenia associated with iron deficiency anemia. Clin Pediatr 1966; 5:609-18.
84. Gross S, Keefer V, Newman AJ. The platelets in iron-deficiency anemia. I. The response to oral and parenteral iron. Pediatrics 1964; 34:315-23.
85. Soff GA, Levin J. Thrombocytopenia associated with repletion of iron in iron-deficiency anemia. Am J Med Sci 1988; 295:35-9.
86. Kimura H, Finch CA, Adamson JW. Hematopoiesis in the rat: quantitation of hematopoietic progenitors and the response to iron deficiency anemia. J Cell Physiol 1986; 126:298-306.
87. Cazzola M, Guarnone R, Cerani P, Centenara E, Rovati A, Beguin Y. Red cell precursor mass as an independent determinant of serum erythropoietin level. Blood 1998; 91:2139-45.
88. Beguin Y. Prediction of response to optimize outcome of treatment with erythropoietin. Semin Oncol 1998; 25 (Suppl.7):27-34.
89. Loo M, Beguin Y. The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. Blood 1999 (in press).
90. Visvader J, Adams JM. Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression. Blood 1993; 82:1493-501.
91. Romeo PH, Prandini MH, Joulin V, et al. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature 1990; 344:447-9.
92. Martin DI, Zon LI, Mutter G, Orkin SH. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages. Nature 1990; 344:444-7.
93. Higuchi T, Koike K, Sawai N, Koike T. Proliferate and differentiative potential of thrombopoietin-responsive precursors: expression of megakaryocytic and erythroid lineages. Exp Hematol 1997; 25:463-70.
94. Papayannopoulou T, Brice M, Farrer D, Kaushansky K. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy. Exp Hematol 1996; 24:660-9.
95. Tabilio A, Rosa JP, Testa U, et al. Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL). Embo J 1984; 3:453-9.
96. Morgan DA, Class R, Soslau G, Brodsky I. Cytokine-mediated erythroid maturation in megakaryoblastic human cell line HU-3. Exp Hematol 1997; 25:1378-85.
97. Bonsi L, Grossi A, Strippoli P, et al. An erythroid and megakaryocytic common precursor cell line (B1647) expressing both c-mpl and erythropoietin receptor (Epo-R) proliferates and modifies globin chain synthesis in response to megakaryocyte growth and development factor (MGDF) but not to erythropoietin (Epo). Br J Haematol 1997; 98:549-59.
98. Komatsu N, Kirito K, Shimizu R, et al. In vitro development of erythroid and megakaryocytic cells from a UT-7 subline, UT-7/GM. Blood 1997; 89:4021-33.
99. Bellucci S, Han ZC, Pidard D, Caen JP. Identification of a normal human bone marrow cell population co-expressing megakaryocytic and erythroid markers in culture. Eur J Haematol 1992; 48:259-65.
100. Debili N, Coulombel L, Croisille L, et al. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood 1996; 88:1284-96.
101. Ward CS, Westwood NB, Emmerson AJ, Pearson TC. The in vitro effect of high-dose recombinant human erythropoietin on granulocyte-macrophage colony production in premature infants using a defined serum deprived cell culture system. Br J Haematol 1992; 81:325-30.